Table 5. CYP1B1 mutations detected in the PCG and ARS families studied from EMEIGG.
Family No. | Patient No. | Phenotype | Mutation 1 | Mutation 2 | Treatment and prognosis |
---|---|---|---|---|---|
EMEIGG-10004 |
IV:1* |
PCG |
p.Trp57Stop |
p.Ser464PhefsX12 |
One eye badly impaired treated with trabeculectomy and tube implantation, the other with moderate phenotype and good response to goniotomy and trabeculectomy |
EMEIGG-12005 |
I:1 |
Normal |
- |
p.Leu277Stop |
*Severe phenotype, one eye enucleated after repeated filtering surgeries and the other with advanced damage but IOP controlled medically |
I:2 |
Normal |
p.Gly61Glu |
- |
||
II:2* |
PCG |
p.Gly61Glu |
p.Leu277Stop |
||
II:3 |
Normal |
- |
p.Leu277Stop |
||
III:1 |
Normal |
- |
p.Leu277Stop |
||
III:2 |
Normal |
- |
p.Leu277Stop |
||
EMEIGG-12008 |
I:2 |
POAG |
p.Ala179ArgfsX16 |
p.Arg368His |
I:2, mild POAG phenotype
II:1, one eye with severe phenotype (2 trabeculectomies) and the other moderate (2 trabeculectomies)
II:2, OHT with initial damage at OCT with normal visual fields, medical treatment initiated |
II:1* |
JOAG |
p.Ala179ArgfsX16 |
p.Arg468_Ser476dup |
||
II:2 |
Normal |
p.Arg368His |
p.Arg468_Ser476dup |
||
II:3 |
Normal |
- |
p.Arg368His |
||
III:1 |
Normal |
- |
p.Arg468_Ser476dup |
||
III:2 |
Normal |
- |
p.Arg368His |
||
III:3 |
Normal |
- |
p.Arg468_Ser476dup |
||
III:4 |
Normal |
- |
p.Arg468_Ser476dup |
||
EMEIGG-20004 |
I:1 |
Normal |
- |
- |
*Unilateral PCG with severe damage treated with trabeculectomy and tube implantation |
I:2 |
Normal |
- |
p.Arg368His |
||
II:1 |
Normal |
- |
p.Arg368His |
||
II:2* |
PCG |
- |
p.Arg368His |
||
HCL-21 | G-271* | POAG | p.Tyr81Asn | - | Severe bilateral damage treated with tube implantation but presence of neovascular glaucoma secondary to diabetic retinopathy |
Index patients are indicated by an asterisk.